⚕️
Medikal Tanı ve Test Sektörü Hisseleri
Medikal Tanı ve Test Sektörü altında 235 Hisse Senedi
Medikal Tanı ve Test sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
235
Toplam Hisse
$2.2T
Toplam Piyasa Değeri
Medikal Tanı ve Test Sektörü Hisseleri
Sayfa 2/3 (Toplam: 235)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM | |
|---|---|---|---|---|---|
| PSNL | Personalis, Inc. | $430.58M | $4.63 | 0.87% | |
| SIGA | SIGA Technologies, Inc. | $422.46M | $5.98 | 2.92% | |
| FTRE | Fortrea Holdings Inc. | $421.01M | $4.30 | 2.87% | |
| LAB | Standard BioTools Inc. | $417.80M | $1.01 | 4.72% | |
| PRTC | PureTech Health plc | $401.60M | $18.43 | 1.74% | |
| ABSI | Absci Corporation | $377.54M | $2.65 | 3.28% | |
| SENS | Senseonics Holdings, Inc. | $376.28M | $0.52 | 1.95% | |
| MYGN | Myriad Genetics, Inc. | $373.78M | $4.19 | 0.72% | |
| TECX | Tectonic Therapeutic, Inc. | $368.88M | $21.51 | 3.97% | |
| CTKB | Cytek Biosciences, Inc. | $363.51M | $2.77 | 6.95% | |
| OM | Outset Medical, Inc. | $336.72M | $17.57 | 0.23% | |
| PACB | Pacific Biosciences of California, Inc. | $334.59M | $0.96 | 7.34% | |
| CAPR | Capricor Therapeutics, Inc. | $333.44M | $9.89 | 1.98% | |
| ARCT | Arcturus Therapeutics Holdings Inc. | $321.65M | $12.53 | 1.57% | |
| SMLR | Semler Scientific, Inc. | $316.68M | $40.00 | 0.20% | |
| EBS | Emergent BioSolutions Inc. | $313.73M | $6.32 | 2.17% | |
| MRVI | Maravai LifeSciences Holdings, Inc. | $287.92M | $2.25 | 5.06% | |
| QSI | Quantum-Si incorporated | $281.13M | $1.68 | 1.75% | |
| AURA | Aura Biosciences, Inc. | $264.41M | $5.86 | 3.78% | |
| CERS | Cerus Corporation | $250.42M | $1.27 | 3.25% | |
| MG | Mistras Group, Inc. | $245.16M | $7.55 | 2.17% | |
| PROK | ProKidney Corp. | $228.16M | $0.72 | 0.32% | |
| TOI | The Oncology Institute, Inc. | $210.72M | $3.19 | 0.62% | |
| NEO | NeoGenomics, Inc. | $207.44M | $7.28 | 1.22% | |
| ANNX | Annexon, Inc. | $192.00M | $2.04 | 6.42% | |
| CATX | Perspective Therapeutics, Inc. | $188.83M | $2.57 | 4.81% | |
| OSUR | OraSure Technologies, Inc. | $188.12M | $2.88 | 1.41% | |
| INMB | INmune Bio, Inc. | $177.79M | $7.38 | 0.27% | |
| OABI | OmniAb, Inc. | $177.28M | $1.27 | 1.60% | |
| CTMX | CytomX Therapeutics, Inc. | $174.05M | $2.65 | 5.16% | |
| ARAY | Accuray Incorporated | $171.00M | $1.53 | 3.16% | |
| QTRX | Quanterix Corporation | $163.08M | $5.20 | 0.67% | |
| INBX | Inhibrx Biosciences, Inc. | $161.41M | $13.47 | 2.04% | |
| MASS | 908 Devices Inc. | $153.32M | $5.68 | 2.91% | |
| DCGO | DocGo Inc. | $152.62M | $1.42 | 4.41% | |
| BIOA | BioAge Labs, Inc. | $143.04M | $3.96 | 0.50% | |
| TNGX | Tango Therapeutics, Inc. | $139.29M | $2.22 | 4.72% | |
| LUNG | Pulmonx Corporation | $132.85M | $3.40 | 6.25% | |
| RPID | Rapid Micro Biosystems, Inc. | $131.92M | $3.33 | 1.19% | |
| SEER | Seer, Inc. | $127.63M | $1.92 | 0.52% | |
| LUCD | Lucid Diagnostics Inc. | $126.46M | $1.39 | 8.55% | |
| ATOS | Atossa Therapeutics, Inc. | $114.96M | $0.78 | 2.18% | |
| ALEC | Alector, Inc. | $110.99M | $1.33 | 6.34% | |
| ICAD | iCAD, Inc. | $108.00M | $3.84 | 5.21% | |
| LCTX | Lineage Cell Therapeutics, Inc. | $107.97M | $0.66 | 3.10% | |
| NAUT | Nautilus Biotechnology, Inc. | $106.69M | $0.75 | 6.58% | |
| COYA | Coya Therapeutics, Inc. | $99.56M | $5.33 | 0.03% | |
| MGNX | MacroGenics, Inc. | $97.16M | $1.36 | 2.86% | |
| AADI | Aadi Bioscience, Inc. | $94.89M | $2.05 | 2.38% | |
| GNLX | Genelux Corporation | $92.64M | $2.42 | 1.63% | |
| AGEN | Agenus Inc. | $91.84M | $3.43 | 7.19% | |
| SAVA | Cassava Sciences, Inc. | $89.37M | $2.01 | 1.47% | |
| ANIX | Anixa Biosciences, Inc. | $85.97M | $2.57 | 1.53% | |
| SNTI | Senti Biosciences, Inc. | $83.20M | $3.14 | 0.96% | |
| GALT | Galectin Therapeutics Inc. | $83.08M | $1.31 | 5.65% | |
| SERA | Sera Prognostics, Inc. | $82.40M | $1.56 | 4.88% | |
| OCX | OncoCyte Corporation | $75.18M | $3.32 | 1.84% | |
| JSPR | Jasper Therapeutics, Inc. | $73.76M | $5.50 | 3.17% | |
| TCRX | TScan Therapeutics, Inc. | $71.59M | $1.43 | 2.72% | |
| NOTV | Inotiv, Inc. | $68.53M | $2.60 | 7.14% | |
| INO | Inovio Pharmaceuticals, Inc. | $68.03M | $2.00 | 6.10% | |
| IGMS | IGM Biosciences, Inc. | $67.55M | $1.27 | 4.51% | |
| PYXS | Pyxis Oncology, Inc. | $67.21M | $1.21 | 3.20% | |
| ANRO | Alto Neuroscience, Inc. | $64.16M | $2.58 | 4.09% | |
| MCRB | Seres Therapeutics, Inc. | $63.83M | $7.05 | 0.56% | |
| ABOS | Acumen Pharmaceuticals, Inc. | $63.60M | $1.02 | 2.86% | |
| STRO | Sutro Biopharma, Inc. | $62.38M | $0.90 | 0.26% | |
| PDSB | PDS Biotechnology Corporation | $60.52M | $1.38 | 1.43% | |
| BEAT | HeartBeam, Inc. | $57.67M | $1.70 | 10.39% | |
| CUE | Cue Biopharma, Inc. | $57.49M | $0.64 | 0.93% | |
| IMMX | Immix Biopharma, Inc. | $56.03M | $2.34 | 4.00% | |
| RENB | Renovaro Biosciences Inc. | $55.23M | $0.31 | 1.68% | |
| MAIA | MAIA Biotechnology, Inc. | $54.70M | $1.79 | 1.10% | |
| BDSX | Biodesix, Inc. | $52.59M | $0.30 | 7.22% | |
| OMIC | Singular Genomics Systems, Inc. | $50.77M | $20.01 | 0.00% | |
| AKYA | Akoya Biosciences, Inc. | $50.62M | $1.25 | 0.81% | |
| RNTX | Rein Therapeutics Inc. | $49.48M | $1.95 | 0.52% | |
| OPGN | OpGen, Inc. | $48.83M | $4.70 | 2.29% | |
| IKNA | Ikena Oncology, Inc. | $46.92M | $1.19 | 0.85% | |
| HYPR | Hyperfine, Inc. | $46.78M | $0.60 | 0.58% | |
| LTRN | Lantern Pharma Inc. | $45.45M | $3.05 | 2.56% | |
| IMRX | Immuneering Corporation | $44.98M | $1.71 | 0.89% | |
| CELU | Celularity Inc. | $44.79M | $2.11 | 7.46% | |
| STTK | Shattuck Labs, Inc. | $43.48M | $1.01 | 6.48% | |
| CCEL | Cryo-Cell International, Inc. | $40.80M | $5.12 | 0.39% | |
| BOLD | Boundless Bio, Inc. | $34.57M | $1.10 | 5.98% | |
| FBLG | FibroBiologics, Inc. Common Stock | $32.37M | $0.73 | 2.73% | |
| FEMY | Femasys Inc. | $29.56M | $0.88 | 13.73% | |
| ALXO | ALX Oncology Holdings Inc. | $25.71M | $0.49 | 3.92% | |
| BCAB | BioAtla, Inc. | $25.68M | $0.41 | 4.60% | |
| IPA | ImmunoPrecise Antibodies Ltd. | $22.88M | $0.57 | 0.73% | |
| CVM | CEL-SCI Corporation | $21.52M | $2.10 | 11.02% | |
| OVID | Ovid Therapeutics Inc. | $21.06M | $0.27 | 9.54% | |
| LGVN | Longeveron Inc. | $20.56M | $1.24 | 5.34% | |
| ELEV | Elevation Oncology, Inc. | $20.45M | $0.30 | 1.96% | |
| NNVC | NanoViricides, Inc. | $19.78M | $1.52 | 3.18% | |
| ENZ | Enzo Biochem, Inc. | $16.44M | $0.31 | 17.77% | |
| PMD | Psychemedics Corporation | $15.74M | $2.67 | 0.00% | |
| PRPH | ProPhase Labs, Inc. | $15.49M | $0.37 | 1.23% | |
| ERNA | Eterna Therapeutics Inc. | $13.71M | $0.22 | 4.80% |